278 related articles for article (PubMed ID: 33644224)
1. Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review.
Hoffmann-Vold AM; Maher TM; Philpot EE; Ashrafzadeh A; Distler O
ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33644224
[TBL] [Abstract][Full Text] [Related]
2. High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients.
Ruaro B; Baratella E; Confalonieri P; Wade B; Marrocchio C; Geri P; Busca A; Pozzan R; Andrisano AG; Cova MA; Confalonieri M; Salton F
Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829307
[TBL] [Abstract][Full Text] [Related]
3. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Rahaghi FF; Hsu VM; Kaner RJ; Mayes MD; Rosas IO; Saggar R; Steen VD; Strek ME; Bernstein EJ; Bhatt N; Castelino FV; Chung L; Domsic RT; Flaherty KR; Gupta N; Kahaleh B; Martinez FJ; Morrow LE; Moua T; Patel N; Shlobin OA; Southern BD; Volkmann ER; Khanna D
Respir Res; 2023 Jan; 24(1):6. PubMed ID: 36624431
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
5. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
6. Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.
Chatterjee S; Perelas A; Yadav R; Kirby DF; Singh A
Clin Rheumatol; 2023 Mar; 42(3):653-661. PubMed ID: 36271064
[TBL] [Abstract][Full Text] [Related]
7. Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease in Brazil: A Real-Life, Long-Term Follow-up Observational Study.
de Oliveira Martins LV; Oliveira SM; Silvatti J; de Amorim FG; Agapito Tito CV; Kayser C
J Clin Rheumatol; 2022 Mar; 28(2):e532-e538. PubMed ID: 34609336
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
[TBL] [Abstract][Full Text] [Related]
9. Predictors of progression in systemic sclerosis patients with interstitial lung disease.
Distler O; Assassi S; Cottin V; Cutolo M; Danoff SK; Denton CP; Distler JHW; Hoffmann-Vold AM; Johnson SR; Müller Ladner U; Smith V; Volkmann ER; Maher TM
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32079645
[TBL] [Abstract][Full Text] [Related]
10. Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis.
Khanna SA; Nance JW; Suliman SA
Curr Rheumatol Rep; 2022 May; 24(5):166-173. PubMed ID: 35499699
[TBL] [Abstract][Full Text] [Related]
11. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors.
Forestier A; Le Gouellec N; Béhal H; Kramer G; Perez T; Sobanski V; Dubois SM; Lambert M; Hatron PY; Hachulla E; Duhamel A; Matran R; Launay D; Rémy-Jardin M
Semin Arthritis Rheum; 2020 Dec; 50(6):1406-1413. PubMed ID: 32245698
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests.
Carnevale A; Silva M; Maietti E; Milanese G; Saracco M; Parisi S; Bravi E; De Gennaro F; Arrigoni E; Bodini FC; Fusaro E; Scirè CA; Sverzellati N; Ariani A
Clin Rheumatol; 2021 Jan; 40(1):213-219. PubMed ID: 32880053
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the management of systemic sclerosis-associated interstitial lung disease.
Hoffmann-Vold AM; Distler O; Crestani B; Antoniou KM
Curr Opin Pulm Med; 2022 Sep; 28(5):441-447. PubMed ID: 35855572
[TBL] [Abstract][Full Text] [Related]
14. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
Chung JH; Walker CM; Hobbs S
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.
Winstone TA; Assayag D; Wilcox PG; Dunne JV; Hague CJ; Leipsic J; Collard HR; Ryerson CJ
Chest; 2014 Aug; 146(2):422-436. PubMed ID: 24576924
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis associated interstitial lung disease: a survey of current practices in France.
Nicolas A; Leroy S; Mouthon L; Uzunhan Y; Cottin V; Mekinian A; Queyrel V; Hachulla E; Gachet B; Launay D; Martis N;
Ther Adv Musculoskelet Dis; 2023; 15():1759720X231159712. PubMed ID: 37187855
[TBL] [Abstract][Full Text] [Related]
17. Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses.
Fields A; Potel KN; Cabuhal R; Aziri B; Stewart ID; Schock BC
Thorax; 2023 Aug; 78(8):799-807. PubMed ID: 36261273
[TBL] [Abstract][Full Text] [Related]
18. Worsening of esophageal dilatation is associated with increase in a high-resolution computed tomography (HRCT) score in early systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Wangkaew S; Losuriya P; Euathrongchit J
Clin Rheumatol; 2021 Mar; 40(3):955-963. PubMed ID: 32803568
[TBL] [Abstract][Full Text] [Related]
19. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.
Gargani L; Bruni C; De Marchi D; Romei C; Guiducci S; Bellando-Randone S; Aquaro GD; Pepe A; Neri E; Colagrande S; Falaschi F; Moggi-Pignone A; Pingitore A; Matucci-Cerinic M
Clin Rheumatol; 2021 May; 40(5):1903-1912. PubMed ID: 33161470
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.
Young A; Vummidi D; Visovatti S; Homer K; Wilhalme H; White ES; Flaherty K; McLaughlin V; Khanna D
Arthritis Rheumatol; 2019 Aug; 71(8):1339-1349. PubMed ID: 30762947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
